CLOSE X
GO

ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)

very highequitypharma & health care
37.57 0.50(1.35%) NAV as on 23 Apr 2025
1.79 % 1 M
24.4 % 1 Y
23.98 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

To generate long-term capital appreciation by creating a portfolio that is invested in Equity and Equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.However there can be no assurance that the investment objectives of the scheme will be realized.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

1.94

As on 31 Mar, 2025
age-icon Age :

6 yrs 9 m

Since 13 07 ,2018
exit_load Exit Load :

1%

aum AUM :

4,914.64 Crs

lock_in Lock-in :

1% on or before 15D, Nil after 15D

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

5.77

Min_Investment Min. Investment :

SIP 100 & Lumpsum 5000

Scheme_benchmark Scheme Benchmark :

NA

Fund_manager Fund Manager :

Dharmesh Kakkad

LATEST ASSET & PORTFOLIO ALLOCATION

as on Mar 31 ,2025
Others 1.72 %
Equity 98.28 %

TOP HOLDINGS

Sun Pharmaceutical Industries...13.50 %
Dr. Reddy's Laboratories Ltd.8.95 %
Cipla Ltd.8.85 %
Divi's Laboratories Ltd.6.71 %
Aurobindo Pharma Ltd.5.30 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs81.44
Hospital & Healthcare Services4.86
Chemicals4.45
Business Support4.33
Insurance2.13
See All Sectors

5-YEARS HISTORY

Financial Year2020-20212021-20222022-20232023-20242024-2025
NAV in Rs (as on 31-Mar-2025)17.3519.6918.6430.2036.20
Net Assets(Rs Crores) (as on 31-Mar-2025) 2213.63 2500.42 2594.59 3772.32 4914.64
Scheme Returns(%)(Absolute)83.7912.51-5.3861.1518.22
B'mark Returns(%)(Absolute)NANANANANA
Category Rank19/7547/7563/7612/906/102

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity37.570.50(1.35%)NAV As on 23 Apr, 202513-Jul-2018Inception Date4,914.64AUM In Cr.24.40%1Y23.98%3Y25.65%5Y21.55%Since Inception
SBI Healthcare Opp Fund-Reg(G)Very HighEquity422.773.97(0.95%)NAV As on 23 Apr, 202514-Jul-1999Inception Date3,610.51AUM In Cr.23.07%1Y23.25%3Y25.34%5Y16.32%Since Inception
Tata India Pharma & Healthcare Fund-Reg(G)Very HighEquity29.620.35(1.19%)NAV As on 23 Apr, 202528-Dec-2015Inception Date1,183.65AUM In Cr.20.10%1Y20.07%3Y22.33%5Y12.35%Since Inception
Nippon India Pharma Fund(G)Very HighEquity499.133.63(0.73%)NAV As on 23 Apr, 202505-Jun-2004Inception Date8,080.97AUM In Cr.18.80%1Y19.79%3Y22.59%5Y20.58%Since Inception
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors